This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
Guo Mei (Chinese: 郭梅; pinyin: Guō Méi, born January, 1968) is a hematologist and associate director of 307th Hospital of Chinese People’s Liberation Army and deputy director of Radiation Research Institute.[1][2][3][4]
Guo Mei is a Chinese physician who works with Huisheng Ai. She graduated from Academy of Military Medical Sciences and got master degree in 1997. She is a pre-eminent expert in the use of hematopoietic stem cell transplantation for treating radiation injuries and blood disease, especially leukemia, aplastic anemia and myelodysplastic syndrome.[5][6][7][8][9][10]
She is one of the founders of microtransplantation. Years of education and research experience in microtransplantation have earned her a large amount of respect from her colleagues. Her expertise is reflected in the awards and recognition she has received.[11]
Guo Mei brings her passion and knowledge for treating blood disease with microtransplantation in 307th Hospital, and with an equally dedicated medical and support team, works hard every day to improve the quality of lives of the patients.
1998 Dr. Guo and her medical team developed "Study of HLA-matched nonmyeloablative transplantation in the treatment of hematological malignancies" successfully.
2004 The study of HLA haploidentical blood related and unrelated matched donors nonmyeloablative transplantation for the treatment of blood diseases.
2005 Treatment of Jining serious radiation accidents and extremely severe bone marrow and intestinal radiation
2006 Developed an original creativity of microtransplantation for the treatment of leukemia. This technology opens up new opportunities for treating leukemia in world.
From 2010 to 2015, she took part in 12 projects of national 863 and provincial projects. As the first applicants, she took five scientific research projects, including the National Ministry of science and Technology Department project, National 11th Five-Year Plan key project of scientific and technological and National 12th Five-Year Plan key project of scientific and technological.[12]
Her accomplishments include over 100 published research articles, including four articles that have been recorded by SCI (JCO: 18.4, Blood: 10.55, BBMT 3.86) aplastic anemia and myelodysplastic syndrome.[13][14][15] She has co-authored five monographs, including "Hematopoietic stem cell transplantation clinical and basic," "Modern leukemia study," "Clinical and basic research of radiation sickness," and two more books.
This section may contain excessiveorirrelevant examples. Please help improve the article by adding descriptive text and removing less pertinent examples. (September 2020)
|
